NCT00399087View on ClinicalTrials.gov

Phase I Trial of Docetaxel With Perifosine

PHASE1CompletedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2011

Conditions

Neoplasms

Interventions

DRUG

Perifosine

Perifosine oral administration

DRUG

Docetaxel

IV administration

DRUG

Prednisone

Oral administration

Trial Locations (1)

37604

Investigative Site, Johnson City

Sponsors

Lead Sponsor

AEterna Zentaris

All Listed Sponsors

lead

AEterna Zentaris

INDUSTRY